Forward Citations = 97

Loading Chart...

4 inventors (with patents filed for the assignee):

Wang Shen (4 out of 45 patents)

Min Zhong (4 out of 41 patents)

Johan D Oslob (4 out of 38 patents)

4. Kenneth Jay Barr (4 out of 44 patents)

4 patents: Sort by Forward Citations

1. 7989626 - Modulators of cellular adhesion (2011-08-02),

2. 7928122 - Modulators of cellular adhesion (2011-04-19),

3. 7790743 - Modulators of cellular adhesion (2010-09-07),

4. 7745460 - Modulators of cellular adhesion (2010-06-29),

Sarcode Corporation is a leading biotechnology company specializing in developing innovative therapies for rare genetic diseases. With a focus on precision medicine, Sarcode's research and development team is dedicated to identifying and targeting specific genetic mutations to deliver personalized treatments for patients. The company's pipeline includes several promising drug candidates with the potential to address unmet medical needs in a range of rare diseases.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#27 in Brisbane, CA

#14,036 in California

#60,561 in US

Brisbane, CA, United States of America

Sarcode Corporation

Forward Citations = 97

4 inventors:

Wang Shen (4 out of 45 patents)

Min Zhong (4 out of 41 patents)

Johan D Oslob (4 out of 38 patents)

4. Kenneth Jay Barr (4 out of 44 patents)

Please report any incorrect information to [email protected]